GlassScriptPhysician profile
Alexandra Rose Mudd
NPI 1548737331
$1,538.47
in general payments reported to CMS, 2019-2025
22 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $32.37 · 2023: $862 · 2024: $101 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $661 · Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $660.65 |
| Food and Beverage | $544.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $795.25 | 2022-2023 | Rosa, Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $108.81 | 2023-2025 | Euflexxa |
| Dynasplint Systems INC. | $95.90 | 2021 | |
| Pacira Therapeutics, INC. | $84.17 | 2021 | |
| Smith+Nephew, INC. | $60.17 | 2024-2025 | Pico 7, Pico 14, Renasys Touch |
| Pacira Pharmaceuticals Incorporated | $44.39 | 2023-2025 | Zilretta, Iovera, Exparel |
| Orthofix Medical, INC. | $41.83 | 2025 | Tl-Hex Truelok Hexapod System |
| Alpha Orthopedic Systems | $40.06 | 2021 | |
| Bioventus LLC | $38.15 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $34.81 | 2024-2025 | |
| Convatec INC. | $26.56 | 2025 | |
| Davol INC. | $21.87 | 2025 | Channel Drain |
| Sanofi-Aventis U.S. LLC | $19.85 | 2021 | |
| Precision Medical Products INC. | $16.34 | 2021 | |
| Melinta Therapeutics, LLC | $15.88 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.59 | 2024 | Prolia, Evenity |
| Abbvie INC. | $15.14 | 2025 | |
| Integra Lifesciences Corporation | $14.47 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Vericel Corporation | $14.32 | 2023 | Maci |
| Endo Pharmaceuticals INC. | $13.91 | 2021 | |
| Depuy Synthes Sales INC. | $12.52 | 2021 | |
| Next Science LLC | $8.48 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Mudd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.